Molecular Epidemiologic Study of Male Trichomoniasis in Hamadan, Western Iran
Background: Trichomoniasis, caused by Trichomonas vaginalis protozoan, may lead to clinical or subclinical urethritis or prostatitis in men. Despite the importance of men in the epidemiology of trichomoniasis, there is little information about this topic. This epidemiological study was performed on men in Hamedan, western Iran.
Methods: During Oct 2018 to Mar 2019, 214 male individuals, presenting to the Urology Clinic of Shahid Beheshti Hospital in Hamadan, were enrolled and evaluated for trichomoniasis. First-voided urine specimen was used for detection of T. vaginalis infection using molecular and parasitological methods.
Results: Trichomoniasis was detected in 10 of 214 male participants (4.7%, 95% CI: 7.5-1.8%) using PCR assay. Culture and wet mount preparation of urine sediment were unable to isolates any T. vaginalis parasite. Nine of the 10 infected men were married, and six of them were ≥49 yr of age. Urinary frequency and dysuria were the most complaints (80%) among infected individuals.
Conclusion: Given the notable prevalence of the infection, the prevalence of male trichomoniasis will be underestimated if only conventional diagnostic methods are used. Therefore, the risk of infection as well as the molecular survey of T. vaginalis infection should be considered in men with or without clinical symptoms.
2. Kissinger P. Trichomonas vaginalis: a review of epidemiologic, clinical and treatment is-sues. BMC Infect Dis. 2015; 15:307.
3. Mercer F, Johnson PJ. Trichomonas vaginalis: Pathogenesis, Symbiont Interactions, and Host Cell Immune Responses. Trends Parasitol. 2018; 34(8):683–93.
4. Schwebke JR, Burgess D. Trichomoniasis. Clin Microbiol Rev. 2004; 17(4):794-803.
5. Poole DN, McClelland RS. Global epide-miology of Trichomonas vaginalis. Sex Transm Infect. 2013; 89(6):418–22.
6. Joyner JL, Douglas JM, Ragsdale S, et al. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis. 2000; 27(4):236-40.
7. Schwebke JR, Hook EW. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implica-tions for screening and urethritis man-agement. J Infect Dis. 2003; 188(3):465-68.
8. Muzny CA, Blackburn RJ, Sinsky RJ, et al. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis. 2014; 59(6):834-41.
9. Lewis DA, Marsh K, Radebe F, et al. Trends and associations of Trichomonas vaginalis infection in men and women with genital discharge syndromes in Johannes-burg, South Africa. Sex Transm Infect. 2013; 89(6):523-7.
10. Seña AC, Miller WC, Hobbs MM, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treat-ment, and prevention. Clin Infect Dis. 2007; 44(1):13-22.
11. Seo JH, Yang HW, Joo SY, et al. Preva-lence of Trichomonas vaginalis by PCR in Men Attending a Primary Care Urology Clinic in South Korea. Korean J Parasitol. 2014; 52(5):551–55.
12. Lawing LF, Hedges SR, Schwebke JR. De-tection of Trichomoniasis in Vaginal and Urine Specimens from Women by Culture and PCR. J Clin Microbiol. 2000; 38(10):3585–8.
13. Matini M, Rezaie S, Mohebali M, et al. Prevalence of Trichomonas vaginalis Infection in Hamadan City, Western Iran. Iran J Par-asitol. 2012;7(2):67–72.
14. Crucitti T, Dyck EV, Tehe A, et al. Com-parison of culture and different PCR as-says for detection of Trichomonas vaginalis in self-collected vaginal swab specimens. Sex Transm Infect. 2003; 79(5):393–8.
15. Wendel K, Erbelding E, Gaydos C, et al. Use of urine polymerase chain reaction to define the prevalence and clinical presenta-tion of Trichomonas vaginalis in men attend-ing an STD clinic. Sex Transm Infect. 2003; 79(2):151–3.
16. Secor WE, Meites E, Starr MC, et al. Ne-glected Parasitic Infections in the United States: Trichomoniasis. Am J Trop Med Hyg. 2014;90(5):800–4.
17. Hobbs MM, Lapple DM, Lawing LF, et al. Methods for detection of Trichomonas vaginalis in the male partners of infected women: implications for control of trichomoniasis. J Clin Microbiol. 2006;44(11):3994-9.
18. Kaydos-Daniels SC, Miller WC, Hoffman I, et al. The Use of Specimens from Vari-ous Genitourinary Sites in Men, to Detect Trichomonas vaginalis Infection. J Infect Dis. 2004;189(10):1926–31.
19. Seike K, Maeda SL, Kubota Y, et al. Preva-lence and morbidity of urethral Trichomonas vaginalis in Japanese men with or without urethritis. Sex Transm Infect. 2013; 89(6):528–30.
20. Lee JJ, Moon HS,Lee TY, et al. PCR for Diagnosis of Male Trichomonas vaginalis Infection with Chronic Prostatitis and Urethritis. Korean J Parasitol. 2012;50(2):157–159.
21. Arbabi M, Fakhrieh Z, Delavari M, et al. Prevalence of Trichomonas vaginalis infection in Kashan city, Iran (2012-2013). Iran J Reprod Med. 2014;12(7):507–12.
22. Matini M, Rezaei H, Fallah M, et al. Genotyping, Drug Susceptibility and Prevalence Survey of Trichomonas vaginalis among Women Attending Gynecology Clinics in Hamadan, Western Iran, in 2014–2015. Iran J Parasitol. 2017;12(1):29–37.
23. Rabiee s, Bazmani A, Matini M, et al. Comparison of Resistant and Susceptible Strains of Trichomons vaginalis to Metronidazole Using PCR Method. Iran J Parasitol. 2012;7(3):24–30.
24. Akbari Z, Matini M. The Study of Trichomoniasis in Pregnant Women Attending Hamadan City Health Centers in 2015. Avicenna J Clin Microb Infect. 2017;4(2):41533.
|Issue||Vol 16 No 2 (2021)|
|Diagnosis Men Polymerase chain reaction Trichomonas vaginalis Urine|
|Rights and permissions|
|This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.|